Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T16:38:18.038Z.
Calculation as of: 2026-10-06T16:38:18.038Z.
Quote observation: 2026-10-06T16:34:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 71eb9fd1524c6a7909807b3579e07ffedc3dd33f5194760f8552a0f1956527a0
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Market Cap
$8.45M
EV/FCF Ratio
N/A
TTM Avg
12.59x
3Y Avg
12.59x
5Y Avg
12.59x
Market Cap
$7.31M
EV/FCF Ratio
N/A
TTM Avg
41004.37x
3Y Avg
41004.37x
5Y Avg
41004.37x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | $7.95M | N/A | N/A | N/A | N/A |
| GT Biopharma, Inc. (GTBP)vs › | $7.97M | N/A | N/A | N/A | N/A |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.06M | N/A | N/A | N/A | N/A |
| HeartSciences Inc. (HSCS)vs › | $8.19M | N/A | N/A | N/A | N/A |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.59M | N/A | N/A | N/A | N/A |
| DataMEDS AI, Inc. (MEDS)vs › | $8.42M | N/A | N/A | N/A | N/A |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.45M | N/A | 12.59x | 12.59x | 12.59x |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.34M | N/A | N/A | N/A | N/A |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | N/A | 41004.37x | 41004.37x | 41004.37x |
| Skye Bioscience, Inc. (SKYE)vs › | $7.25M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
